Phase II trial of erlotinib in advanced pancreatic cancer.
Phase of Trial: Phase II
Latest Information Update: 12 May 2014
At a glance
- Drugs Erlotinib (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Dec 2008 Basic check conducted, trial sponsor added, last updated 2-12-2008.